1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Haemophilia Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Haemophilia Market Revenues & Volume, 2022 & 2032F |
3.3 China Haemophilia Market - Industry Life Cycle |
3.4 China Haemophilia Market - Porter's Five Forces |
3.5 China Haemophilia Market Revenues & Volume Share, By Treatment, 2022 & 2032F |
3.6 China Haemophilia Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 China Haemophilia Market Revenues & Volume Share, By Diagnosis, 2022 & 2032F |
3.8 China Haemophilia Market Revenues & Volume Share, By Patient, 2022 & 2032F |
3.9 China Haemophilia Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.10 China Haemophilia Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
3.11 China Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 China Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of haemophilia in China |
4.2.2 Growing government investments in healthcare infrastructure and treatment options for haemophilia patients |
4.2.3 Rising prevalence of haemophilia due to factors such as aging population and lifestyle changes |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatment options and therapies in certain regions of China |
4.3.2 High cost associated with haemophilia treatments and therapies, leading to affordability issues for some patients |
4.3.3 Lack of skilled healthcare professionals specialized in haemophilia management |
5 China Haemophilia Market Trends |
6 China Haemophilia Market, By Types |
6.1 China Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Haemophilia Market Revenues & Volume, By Treatment, 2022-2032F |
6.1.3 China Haemophilia Market Revenues & Volume, By Medication, 2022-2032F |
6.1.4 China Haemophilia Market Revenues & Volume, By Desmopressin, 2022-2032F |
6.1.5 China Haemophilia Market Revenues & Volume, By Emicizumab, 2022-2032F |
6.1.6 China Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2022-2032F |
6.1.7 China Haemophilia Market Revenues & Volume, By ITI Therapy, 2022-2032F |
6.1.8 China Haemophilia Market Revenues & Volume, By Gene Therapy, 2022-2032F |
6.1.9 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.1.10 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.2 China Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Haemophilia Market Revenues & Volume, By Oral, 2022-2032F |
6.2.3 China Haemophilia Market Revenues & Volume, By Injectable, 2022-2032F |
6.2.4 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.3 China Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 China Haemophilia Market Revenues & Volume, By Blood Test, 2022-2032F |
6.3.3 China Haemophilia Market Revenues & Volume, By Genetic Tests, 2022-2032F |
6.3.4 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.4 China Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 China Haemophilia Market Revenues & Volume, By Pediatric, 2022-2032F |
6.4.3 China Haemophilia Market Revenues & Volume, By Adult, 2022-2032F |
6.5 China Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 China Haemophilia Market Revenues & Volume, By Haemophilia A, 2022-2032F |
6.5.3 China Haemophilia Market Revenues & Volume, By Haemophilia B, 2022-2032F |
6.5.4 China Haemophilia Market Revenues & Volume, By Haemophilia C, 2022-2032F |
6.5.5 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.6 China Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Haemophilia Market Revenues & Volume, By Hospitals, 2022-2032F |
6.6.3 China Haemophilia Market Revenues & Volume, By Specialty Clinics, 2022-2032F |
6.6.4 China Haemophilia Market Revenues & Volume, By Homecare, 2022-2032F |
6.6.5 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.7 China Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 China Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2022-2032F |
6.7.3 China Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2022-2032F |
6.7.4 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
6.7.5 China Haemophilia Market Revenues & Volume, By Others, 2022-2032F |
7 China Haemophilia Market Import-Export Trade Statistics |
7.1 China Haemophilia Market Export to Major Countries |
7.2 China Haemophilia Market Imports from Major Countries |
8 China Haemophilia Market Key Performance Indicators |
8.1 Number of haemophilia patients diagnosed and under treatment in China |
8.2 Adoption rate of new and advanced treatment options for haemophilia |
8.3 Rate of adherence to treatment plans among haemophilia patients |
9 China Haemophilia Market - Opportunity Assessment |
9.1 China Haemophilia Market Opportunity Assessment, By Treatment, 2022 & 2032F |
9.2 China Haemophilia Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 China Haemophilia Market Opportunity Assessment, By Diagnosis, 2022 & 2032F |
9.4 China Haemophilia Market Opportunity Assessment, By Patient, 2022 & 2032F |
9.5 China Haemophilia Market Opportunity Assessment, By Type, 2022 & 2032F |
9.6 China Haemophilia Market Opportunity Assessment, By End-Users, 2022 & 2032F |
9.7 China Haemophilia Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 China Haemophilia Market - Competitive Landscape |
10.1 China Haemophilia Market Revenue Share, By Companies, 2025 |
10.2 China Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |